Dragon's Blood from Dracaena cochinchinensis

Interstellar grade B

Preclinical: Mechanistic, cell or animal evidence. No single preclinical driver opens a pathway on its own.

Appears on 1 blend page, linked below.

One resin, two named drug targets: loureirin B inhibits PAI-1, loureirin D inhibits the same platelet receptor clopidogrel acts on.

Where it appears

One blend page carries this ingredient. Open it and you will find this ingredient in the list.

• Thrombolytic (Hemostatic Balance)

Pathways it touches